Today's Top Gainer
| SYMBOL | CMP | Chg (%) |
|---|---|---|
Note:Top Gainer - Nifty 50 More
Bafna Pharmaceuticals Ltd Share Price Bafna Pharma.
11.40
Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
11.31
Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
News
Bafna Pharma stock rallies after MHRA renews factory approval
16:44 IST, May 28 | article
The pharma company received renewal certificate from UK MHRA, as per BSE filing.
-
Bafna responds to Exchange's query on investors' names i
9:43 IST, Jan 10 | article
In its response, the company has stated that the type of securities proposed to be issued are share warrants convertible to equity shar
-
Bafna Pharma: Exchange seeks clarification on investors'
12:59 IST, Jan 09 | article
The Exchange has sought clarification from Bafna Pharmaceuticals Limited with respect to the announcement dated Jan 9, 2017, informing
-
Bafna Pharma to consider fresh issue of share warrants;
11:38 IST, Jan 04 | article
A board meeting will be held today to consider withdrawal of entire preferential issue of 40,00,000 share warrants due to inordinate de
-
Bafna Pharma rallies 13% after getting renewal certifica
16:48 IST, Jun 10 | article
The pharma company has received its renewal certificate from Medicines and Healthcare products Regulatory Agency (MHRA), London.
-
Bafna Pharma stock rallies 8%
11:38 IST, Jun 10 | article
The company has got the renewal certificate from Medicines and Healthcare products Regulatory Agency (MHRA), London.
-
Bafna Pharma gets Renewal Certificate from MHRA, London
10:21 IST, Jun 10 | article
The stock of the company is up by 12% at Rs. 27.70.
Healthcare Global Enterprises to announce Quarterly Result
10:39 IST, Jan 19 | article
On 7 February 2019
-
Aurobindo Pharma to acquire portfolio of seven marketed
12:35 IST, Jan 18 | article
Aurobindo Pharma to acquire portfolio of seven marketed oncology injectables products from Spectrum Pharmaceuticals
-
Shilpa Medicare gets USFDA nod for Imatinib Mesylate
12:25 IST, Jan 18 | article
According to IQVIA MAT Q2 2018 data, the US market for Imatinib Mesylate Tablets (100mg and 400mg) is approximately $885mn.
-
Sun Pharma drags Nifty Pharma by ~3%
11:18 IST, Jan 18 | article
Shares of Sun Pharma declined for the second consecutive session after a media report said that fresh whistleblower documents were sent
-
Aurobindo Pharma subsidiary to buy 7 oncology drugs Spec
8:54 IST, Jan 18 | article
According to the definitive agreements inked between the two companies, Acrotech Biopharma LLC, a subsidiary of Aurobindo, will pay an
no news found for the company
-
Asset Quality Challenges in India: Diagnosis and Prognosis
article | 6:28 IST, May 02
Oil and Natural Gas Corporation (ONGC) and OIL India ratings may come under pressure, if oil prices falls fall more sharply than Moody's expects and the companies continue with their growth and expansion plans aggressively
-
Non-subsidised LPG, ATF prices hiked
article | 20:40 IST, May 01
Last year in November 2015, RBI had eased the ECB norms to help Indian companies raising funds through dollar loans. However, a sharp slump in global economy since the beginning of 2016 took a massive toll on ECB with Indian rupees free fall against the US dollar.
-
Green Finance – Early Initiatives
article | 6:32 IST, May 02
The list recognises companies that that put their people first and are committed to providing strong, caring and innovative cultures. More than 1000 companies participated in national list studies in 9 Asia-region countries where Great Place to Work is represented. Of these, the 60 Best Workplaces in Asia were determined.
-
HDFC, TBZ results in focus
article | 6:53 IST, May 02
Singh said that the present stock of wheat with the Food Corporation of India is higher than the stocking norms
-
Tata Power plans to buy Welspun's wind, solar assets
article | 6:23 IST, May 02
RBI said that the foreign currency assets stood at $329.99 bn on March 11.
MY NEWS have to design this tab yet